SERDIA, a subsidiary of the Servier Research Group, is a prominent pharmaceutical company specializing in the development and promotion of original research products in cardiology, metabolism, venous disease, and neuropsychiatry. The company emphasizes scientific innovation and ethical practices in its operations.